Better understanding of the relative contributions of insulin deficiency and insulin resistance may have important implications for clinical management of T2DM, as intensive glucose control by insulin sensitization and/or supplementation strategies offers at best only modest improvements in disease-related morbidity and mortality3,4. The gene discussed is INS; the disease is Insulin resistance.